Uvavanyo lweVOL Cholesterol luya kuhlola Ingozi yakho yeengqondo zeentliziyo?
Uvavanyo lwe-cholesterol lwe-VAP, okanye uvavanyo lwentambo ye-auto, lucacise ngakumbi ukuba uvavanyo lwe-cholesterol oluqhelekileyo okanye ipaneli yepilid. Iquka imilinganiselo ehambelana neenjongo zonyango lwe-cholesterol entsha kwaye inokukhethwa ngababoneleli ababeka iliso kwi-cholesterol ephezulu. Iyakwazi ukuchonga abantu abaninzi abasengozini yesifo senhliziyo kamva ebomini.
Ukuhlolwa kwepropati yecala yemoto (VAP) yaphuhliswa ngabaphandi eBirmington, Alabama kwaye yaqalisa ukuthengiswa ngu-Atherotech, Inc. Ukuthengiswa kwamkelwa yi-FDA ngo-2007.
Uvavanyo lweVAP lufaniswa nePilid Profile yeCholesterol
Uvavanyo lwe-cholesterol yendabuko lusebenza ngokuphalaza ngegazi kwi-centrifuge ephakamileyo kakhulu ukuzahlula i-lipids (amafutha). Olu vavanyo oluqhelekileyo, olubizwa ngokuba yiprofayili ye-lipid, lihlukanisa iintlobo ezintathu zentetho : iipoprotein ephezulu, okanye i-HDL; ii-lipoproteins eziphantsi, okanye i-LDL; kunye ne-triglycerides, uhlobo oluphambili lwamanqatha emzimbeni.
Kodwa malunga nesiqingatha sabo bonke abantu abaye bahlaselwa sisifo senhliziyo, iphrofayili esemgangathweni ye- lipid ayibonakalisi into engafanelekanga. Ngokutsho kwe-Atherotech, uvavanyo lweVAP luyakwazi ukuchonga abantu ababini abasengozini yesifo senhliziyo, xa kuthelekiswa neendlela zobugcisa.
Imilinganiselo yokuhlola i-cholesterol yendabuko:
- Amanqanaba eLDL
- Iindidi zeHDL ezipheleleyo
- Amanqanaba e-Triglyceride
Kwi-test ye-cholesterol yendabuko, la manqanaba abalwa ngokusebenzisa ifom ekhethekileyo. Ngokwahlukileyo, uvavanyo olutsha lweVAP luya kulinganisa la manqanaba ngokuthe ngqo.
Uvavanyo lweVAP
Njengeprofayili yepilid, uvavanyo lweVAP lusebenza ngokutshiza isampuli yegazi ukuhlukanisa i-lipids ngesisindo. Kodwa uvavanyo lweVAP lunikeza iinkcukacha ezingaphezulu kweemvavanyo zendabuko.
Umzekelo, uvavanyo lweVAP luhlukanisa i-cholesterol ye-LDL ngobukhulu obufanayo kunye nokuphula i-cholesterol ye-HDL phantsi kweeklasi. Uphando lwangoku lubonisa ukuba iipatheni ezithile ze-LDL ubuncinci zingabonakalisa umngcipheko omkhulu wokuphuhliswa kwesifo senhliziyo. Ukongezelela, enye i-subclass ye-HDL, i-HDL2, ithathwa njengeyona nto ikhusela intliziyo.
Uvavanyo lweVAP lusetyenzisa ezinye iipilisi zegazi apho iprofayili yepilid yangoku iyalugxeka, njenge-lipoprotein ephantsi kakhulu (VLDL); i-lipoprotein (IDL); kunye ne-lipoprotein (a) [Lp (a)]. Abaphengululi be-Atherotech bathi ukulinganisa ezi zifundo ezongezelelweyo kunye neeklasi zingabonisa ulwazi oluninzi malunga nomngcipheko wokuphulukisa isifo senhliziyo, apho uvavanyo lwendabuko lungaphoswa khona.
Oko iVAP Test Measures
- I-VLDL Iyonke: Amazinga aphezulu e-VLDL ahambelana nobungozi besifo senhliziyo nesifo sikashukela.
- Isisombululo se-Cholesterol Iyonke: Isibalo se-HDL, i-LDL kunye ne-VLDL.
- Iyonke engekho i-HDL: Isamba semali kuphela yeLDL kunye ne-VLDL; Ixabiso eliphezulu libonisa umngcipheko omkhulu wokuhlakulela isifo senhliziyo.
- Iphelele apoB100: I- Apolipoprotein B100 inceda ukudala, ukuthwala nokuhambisa "i-cholesterol embi" kwiiseli; Amanqanaba okulinganisa ama-B100 athomba uhlobo kunye / okanye imbangela ye-cholesterol ephezulu.
- Lp (a) i-cholesterol: uphando lubonisa ukuba i-Lp (a), efana neLDL, iyinzuzo yokufa kwe-atherosclerosis.
- I-IDL: I-lipoprotein yesisindo esiphakathi; ngokwe-Atherotech, eli nani liphakanyisiwe phakathi kwabantu abaneengxaki zentsapho yesifo sikashukela.
- I-LDL-RC: I- LDL eboshwe kwiprotheyini esebenzayo yeC; Olu hlobo lwe-LDL lufumaneka kwisiza se-atherosclerotic plaques emzimbeni, enye yeyona nto impawu eziphambili zesifo se-artery kwaye-xa ziqhekeka-isiseko sokuqala sokuhlaselwa kwentliziyo.
- I-Total Total LDL-C: Isibalo seLp (a), IDL kunye neLDL.
- Umzekelo weLDL: Ukwaziswa njengenye yeentlobo ezintathu - A, A / B okanye B. Kwiphepha A, i-molecule ze-LDL zikhulu kwaye zincinci, okwenza kube lula ukuba umzimba ususe. Kwiphepha A / B, kukho ukudibanisa kwama-molecule alula kunye namazinyo. Kwiphepha B, amancinci amancinci aphezulu aphezulu. Ngokutsho kwe-Atherotech, izigulane ezincinci ezincinane ze-LDL (umzekelo B) zinomngcipheko omkhulu wokukhula kwesifo senhliziyo kunezigulane ezinefayile ye-LDL.
- I-HDL-2: I-subclass "ye-cholesterol enhle" ekhuselekileyo ngokukhusela isifo senhliziyo. Inombolo ephantsi apha ingathetha ingozi eyongezelelekileyo yesifo se-coronary disease, kwanabo banezinga eliqhelekileyo le-cholesterol.
- I-HDL-3: Enye i-subclass ye-HDL, engakhuseliyo kwisifo se-coronary isifo esifanayo ne-HDL-2.
- I-VLDL-3: i-triglyceride ecebile kakhulu i-lipoprotein; ezinye izifundo zibonisa ukulungelelaniswa okuphakathi kwamanani aphezulu e-VLDL-3 kunye nophuhliso lwesifo sikashukela.
Kwakhona, uvavanyo lweVAP lubonelela abantu abanengcamango engcono yokubandezeleka kwabo kwi- syndrome ye-metabolic , idibaniso yezinto eziphakamisa kakhulu umngcipheko umntu uya kuhlakulela isifo sikashukela okanye isifo senhliziyo.
I-Cholesterol yokujoliswa kweenjongo zonyango evela kwi-ADA / ACC 2008 Inkcazo yokubambisana iquka iithagethi ze-LDL-C, engekho i-HDL-C kunye ne-APOB, ezibandakanyiweyo kwi-VAP kodwa ayikho inxalenye yezilingo zokuqala ze-cholesterol.
Imithombo:
Bioletto, Silvana, Alain Golay, uRobert Munger, uBarbara Kalix noRichard W. James. "I-Hyperinsulinemia echanekileyo kunye ne-Low-Low-Density and Low-Density Iifoprotein kwiingqungquthela kwiZifundo ze-Obese." I-American Journal ye-Clinical Nutrition 71 (2000): 443-449.
UCrider, uKristin. "I-Lipoprotein Iphenotype ne-Genotype ekhethekileyo." CDC.gov. 2 Novemba 2007. Amasebe okuLawula izifo.
"Iphepha leNkcazo: I-VAP yeCholesterol Test." Uvavanyo lweCholesterol oluPhezulu kakhulu -VAP . 2008. Atherotech, Inc.
Kulkarni, KR, DW Garber, SM Marcovina kunye noJP Segrest. "Ukukhishwa kweCholesterol kuzo zonke iiCopoprotein Classes ngeVAP-II Method." Umbhalo wePopid Research. 35 (1994) 159-168.
> Abasebenzi beKliniki yabasebenzi. "Uvavanyo lweCholesterol: Ukulunga kwi-Lipids." MayoClinic.com . 1 uFebruwari 2007. I-Clinical Mayo.
"I-Metabolic Syndrome." Syndrome yeMetabolic . 2014. American Association Association.
Singh, SK, MV Suresh, B Voleti kunye ne-Agrawal. "Ukuqhagamshelana phakathi kweP-protein esebenzayo kunye ne-Atherosclerosis." Annals of Medicine. 40.2. 16 I-NOV 2007 110-120.
Ziajka, uPaul. "Ukusebenzisa i-VAP ekwandiseni i-Lipid Testing esuka e-Atherotech ukuze kuphuhliswe iziCwangciso zonyango eziPhezulu eziPheleleyo." 2008. iAtherotech.